Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
arrangement, Bariatric, begun, cast, Castrate, Commodity, construct, contractor, Craniomaxillofacial, deconsolidation, disregarded, DOJ, doubtful, elevated, eye, Fasolo, flat, free, IBD, Idorsia, Incentive, intraocular, laser, Medicine, Metastatic, milestone, modest, Momenta, Peter, phacoemulsification, post, Prostate, reactivated, recast, Resistant, restated, similarly, stake, streamline, successor, transition, written
Removed:
adversary, Alabama, alternative, ALZA, Amax, appointed, Asia, asserting, aveeno, AWP, benzene, Boehringer, calculating, CAMC, Centocor, Chemical, clarifying, commencing, Commonwealth, conduct, consummate, contacted, create, deceleration, defect, dismissing, Dohme, encompassing, Endocutter, enforcing, entry, FCR, Florida, Fort, fraudulent, full, fully, inflated, informal, Ingelheim, intention, Kentucky, Lauderdale, litigate, Merck, modifying, Natco, NDMA, negligible, neutrogena, nondisclosure, Occidental, Oregon, Ortho, OTC, Passaic, Pfizer, pursuing, ranitidine, reserving, restricting, River, Sanofi, Sharp, Skin, strict, strike, subsequent, substance, substituted, sunscreen, suspension, TCC, unsafe, unspecified, urogynecological, USV, warn, Wholesale, Women, York, ZANTAC
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view